95 related articles for article (PubMed ID: 18163183)
1. Cloning and functional characterization of the HRASLS2 gene.
Shyu RY; Hsieh YC; Tsai FM; Wu CC; Jiang SY
Amino Acids; 2008 Jun; 35(1):129-37. PubMed ID: 18163183
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes.
Uyama T; Jin XH; Tsuboi K; Tonai T; Ueda N
Biochim Biophys Acta; 2009 Dec; 1791(12):1114-24. PubMed ID: 19615464
[TBL] [Abstract][Full Text] [Related]
3. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors.
Sers C; Emmenegger U; Husmann K; Bucher K; Andres AC; Schäfer R
J Cell Biol; 1997 Feb; 136(4):935-44. PubMed ID: 9049257
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway.
Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of tumor suppressors TIG3 and H-REV107.
Wei H; Wang L; Ren X; Yu W; Lin J; Jin C; Xia B
FEBS Lett; 2015 May; 589(11):1179-86. PubMed ID: 25871522
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth by p205: a nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation.
Dermott JM; Gooya JM; Asefa B; Weiler SR; Smith M; Keller JR
Stem Cells; 2004; 22(5):832-48. PubMed ID: 15342947
[TBL] [Abstract][Full Text] [Related]
8. p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells.
Perletti G; Marras E; Dondi D; Osti D; Congiu T; Ferrarese R; de Eguileor M; Tashjian AH
Int J Cancer; 2005 Jan; 113(1):42-53. PubMed ID: 15386430
[TBL] [Abstract][Full Text] [Related]
9. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
Rho SB; Park YG; Park K; Lee SH; Lee JH
FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A suppresses proliferation of cervical cancer cells.
Feng L; Li J; Yan LD; Tang J
Asian Pac J Cancer Prev; 2014; 15(14):5917-20. PubMed ID: 25081722
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of RNF26 on human chromosome 11q23 region, encoding a novel RING finger protein with leucine zipper.
Katoh M
Biochem Biophys Res Commun; 2001 Apr; 282(4):1038-44. PubMed ID: 11352657
[TBL] [Abstract][Full Text] [Related]
12. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
14. CYB5D2 displays tumor suppression activities towards cervical cancer.
Xie Y; Shen YT; Kapoor A; Ojo D; Wei F; De Melo J; Lin X; Wong N; Yan J; Tao L; Major P; Tang D
Biochim Biophys Acta; 2016 Apr; 1862(4):556-565. PubMed ID: 26692170
[TBL] [Abstract][Full Text] [Related]
15. PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.
Hagiwara K; Ito H; Murate T; Miyata Y; Ohashi H; Nagai H
Genes Chromosomes Cancer; 2012 Nov; 51(11):1024-36. PubMed ID: 22833470
[TBL] [Abstract][Full Text] [Related]
16. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
17. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.
von Bergh AR; Wijers PM; Groot AJ; van Zelderen-Bhola S; Falkenburg JH; Kluin PM; Schuuring E
Genes Chromosomes Cancer; 2004 Apr; 39(4):324-34. PubMed ID: 14978793
[TBL] [Abstract][Full Text] [Related]
19. RASSF6 is a novel member of the RASSF family of tumor suppressors.
Allen NP; Donninger H; Vos MD; Eckfeld K; Hesson L; Gordon L; Birrer MJ; Latif F; Clark GJ
Oncogene; 2007 Sep; 26(42):6203-11. PubMed ID: 17404571
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
